Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.

BACKGROUND: Botulinum neurotoxin A (BoNT-A) may reduce lower limb spasticity but its role in improving walking ability remains to be established. OBJECTIVE: To investigate the efficacy of simultaneous BoNT-A injections into several targeted spastic muscles of different joints on gait speed and on fu...

Descripción completa

Detalles Bibliográficos

Publicado en:	NeuroRehabilitation Vol. 34; no. 1; pp. 185 - 193
Autores principales:	Cioncoloni, David, Taddei, Sabrina, Bielli, Silvia, Annunziata, Pasquale, Mazzocchio, Riccardo
Formato:	research tables/charts Journal Article
Publicado:	Sage Publications Inc. 2014
Acceso en línea:	Ver este registro en EBSCOhost